Home » Topics » Regulatory » Patents

Patents
RSS

New EGFR inhibitors identified at Lengo Therapeutics

May 26, 2022

Rhizen Pharmaceuticals divulges new PARP inhibitors

May 26, 2022

Newave Pharmaceutical discloses new BTK inhibitors

May 26, 2022

Integral BioSciences patents ENPP1 inhibitors

May 26, 2022

In4Derm Limited presents new BRD4 BD2 inhibitors

May 25, 2022

Chinese researchers identify HSP90A inhibitors

May 25, 2022

Sitryx Therapeutics describes new NFE2L2 activators

May 25, 2022

Shanghai Blueray Biopharma discloses PTPN11 mutant inhibitors

May 25, 2022

Adorx Therapeutics patents new CD73 inhibitors

May 25, 2022

New c-Myc inhibitors presented by Suzhou Kintor Pharmaceuticals

May 24, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...